Veeva Systems EBITDA 2012-2024 | VEEV
Veeva Systems annual and quarterly EBITDA history from 2012 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Veeva Systems EBITDA for the quarter ending October 31, 2024 was $0.189B, a 43.28% increase year-over-year.
- Veeva Systems EBITDA for the twelve months ending October 31, 2024 was $0.666B, a 54.56% increase year-over-year.
- Veeva Systems 2024 annual EBITDA was $0.454B, a 10.47% decline from 2023.
- Veeva Systems 2023 annual EBITDA was $0.507B, a 10.36% decline from 2022.
- Veeva Systems 2022 annual EBITDA was $0.565B, a 31.13% increase from 2021.
| Veeva Systems Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $454 |
| 2023 | $507 |
| 2022 | $565 |
| 2021 | $431 |
| 2020 | $323 |
| 2019 | $253 |
| 2018 | $190 |
| 2017 | $151 |
| 2016 | $90 |
| 2015 | $76 |
| 2014 | $42 |
| 2013 | $31 |
| 2012 | $7 |
| 2011 | $5 |
| Veeva Systems Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-10-31 | $189 |
| 2024-07-31 | $173 |
| 2024-04-30 | $161 |
| 2024-01-31 | $142 |
| 2023-10-31 | $132 |
| 2023-07-31 | $109 |
| 2023-04-30 | $71 |
| 2023-01-31 | $119 |
| 2022-10-31 | $132 |
| 2022-07-31 | $114 |
| 2022-04-30 | $142 |
| 2022-01-31 | $135 |
| 2021-10-31 | $148 |
| 2021-07-31 | $140 |
| 2021-04-30 | $143 |
| 2021-01-31 | $112 |
| 2020-10-31 | $115 |
| 2020-07-31 | $103 |
| 2020-04-30 | $100 |
| 2020-01-31 | $74 |
| 2019-10-31 | $89 |
| 2019-07-31 | $81 |
| 2019-04-30 | $79 |
| 2019-01-31 | $70 |
| 2018-10-31 | $70 |
| 2018-07-31 | $61 |
| 2018-04-30 | $52 |
| 2018-01-31 | $47 |
| 2017-10-31 | $51 |
| 2017-07-31 | $46 |
| 2017-04-30 | $47 |
| 2017-01-31 | $63 |
| 2016-10-31 | $38 |
| 2016-07-31 | $28 |
| 2016-04-30 | $22 |
| 2016-01-31 | $19 |
| 2015-10-31 | $23 |
| 2015-07-31 | $24 |
| 2015-04-30 | $23 |
| 2015-01-31 | $23 |
| 2014-10-31 | $22 |
| 2014-07-31 | $18 |
| 2014-04-30 | $14 |
| 2014-01-31 | $12 |
| 2013-10-31 | $11 |
| 2013-07-31 | $10 |
| 2013-04-30 | $9 |
| 2013-01-31 | |
| 2012-10-31 | $9 |
| 2012-01-31 | |
| 2011-01-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $37.190B | $2.364B |
| Veeva Systems Inc. offers cloud-based software applications and data solutions for the life sciences industry. The company's product portfolio includes Veeva CRM (customer relationship management), Veeva Vault (content and information management), Veeva Network (customer master and product data management) and Veeva data services (Veeva OpenData and Veeva KOL data). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $7.943B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $6.493B | 165.11 |
| Inspire Medical Systems (INSP) | United States | $5.665B | 176.68 |
| IRhythm Technologies (IRTC) | United States | $3.468B | 0.00 |
| Privia Health (PRVA) | United States | $2.722B | 226.80 |
| Enovis (ENOV) | United States | $2.627B | 17.81 |
| Azenta (AZTA) | United States | $2.466B | 131.66 |
| Clover Health Investments (CLOV) | United States | $2.160B | 0.00 |
| 10x Genomics (TXG) | United States | $1.974B | 0.00 |
| Omnicell (OMCL) | United States | $1.974B | 64.58 |
| Schrodinger (SDGR) | United States | $1.773B | 0.00 |
| Phreesia (PHR) | United States | $1.582B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.837B | 0.00 |
| Standard BioTools (LAB) | United States | $0.681B | 0.00 |
| Talkspace (TALK) | United States | $0.534B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.519B | 0.00 |
| TruBridge (TBRG) | United States | $0.342B | 99.65 |
| Health Catalyst (HCAT) | United States | $0.341B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.241B | 0.00 |
| Pulmonx (LUNG) | United States | $0.239B | 0.00 |
| American Well (AMWL) | United States | $0.158B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.092B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.070B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| CareCloud (CCLD) | United States | $0.055B | 0.00 |
| Zepp Health (ZEPP) | China | $0.045B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
| Outset Medical (OM) | United States | $0.041B | 0.00 |
| 111 (YI) | China | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.034B | 0.00 |
| Movano (MOVE) | United States | $0.031B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.020B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.007B | 0.00 |
| Syra Health (SYRA) | United States | $0.005B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |